Cutaneous Mucormycosis in a Patient With Cirrhosis: A Case Report
The global incidence of invasive mucormycosis (mucor) infection is on the rise due in part to an increased utilization of immunosuppressive therapies to treat malignancies and autoimmune diseases. While cirrhosis has previously been considered a risk factor for fungal infections, very little is know...
Saved in:
| Main Authors: | Haley Belt MD, Margaret Kypreos MD, An Lu MD, Ginna Hernandez-Velasquez MD, Roma Mehta MD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-07-01
|
| Series: | Journal of Investigative Medicine High Impact Case Reports |
| Online Access: | https://doi.org/10.1177/23247096251356334 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rhabdomyolysis and Resultant Acute Renal Failure due to Legionella Pneumonia in a Patient with Human Immunodeficiency Virus
by: Margaret Kypreos, et al.
Published: (2023-01-01) -
Management of a pediatric patient with rapidly progressive glomerulonephritis and cutaneous mucormycosis: a case report
by: Lili Jia, et al.
Published: (2025-05-01) -
Right pneumonectomy for invasive pulmonary mucormycosisCentral Message
by: Natalie Van Ochten, BS, et al.
Published: (2022-02-01) -
Cutaneous mucormycosis: Unveiling rare manifestations
by: Jyoti Jindal, et al.
Published: (2025-06-01) -
Cutaneous Mucormycosis Co-infection in a Patient with COVID-19
by: Raham Rahgoshai, et al.
Published: (2022-10-01)